"Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients

Vaccine‐induced thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus‐based vaccines aimed to prevent and minimize COVID‐19 and related pathophysiology. Click to show full abstract

Vaccine‐induced thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus‐based vaccines aimed to prevent and minimize COVID‐19 and related pathophysiology.

Keywords: thrombotic thrombocytopenia; vaccine induced; thrombocytopenia vitt; induced thrombotic

Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended